| pubmed-article:10552188 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0151744 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0019010 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0001645 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0004147 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0340288 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0439799 | lld:lifeskim |
| pubmed-article:10552188 | lifeskim:mentions | umls-concept:C0076034 | lld:lifeskim |
| pubmed-article:10552188 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:10552188 | pubmed:dateCreated | 2000-1-31 | lld:pubmed |
| pubmed-article:10552188 | pubmed:abstractText | Clinical drawbacks of beta-blocker treatment in stable angina have motivated researchers to provide alternative heart rat lowering agents, such as tedisamil which additionally exerts anti-ischemic and antiarrhythmic effects by blockade of cellular repolarizing K(+) currents. | lld:pubmed |
| pubmed-article:10552188 | pubmed:language | ger | lld:pubmed |
| pubmed-article:10552188 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10552188 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10552188 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:10552188 | pubmed:issn | 0300-5860 | lld:pubmed |
| pubmed-article:10552188 | pubmed:author | pubmed-author:ThormannJJ | lld:pubmed |
| pubmed-article:10552188 | pubmed:author | pubmed-author:PitschnerHH | lld:pubmed |
| pubmed-article:10552188 | pubmed:author | pubmed-author:StraubMM | lld:pubmed |
| pubmed-article:10552188 | pubmed:author | pubmed-author:MitrovicVV | lld:pubmed |
| pubmed-article:10552188 | pubmed:author | pubmed-author:BeckmannKK | lld:pubmed |
| pubmed-article:10552188 | pubmed:author | pubmed-author:MiskovicAA | lld:pubmed |
| pubmed-article:10552188 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10552188 | pubmed:volume | 88 | lld:pubmed |
| pubmed-article:10552188 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10552188 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10552188 | pubmed:pagination | 838-49 | lld:pubmed |
| pubmed-article:10552188 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:meshHeading | pubmed-meshheading:10552188... | lld:pubmed |
| pubmed-article:10552188 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10552188 | pubmed:articleTitle | [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol]. | lld:pubmed |
| pubmed-article:10552188 | pubmed:affiliation | Kerckhoff-Klinik GmbH, Benekestr. 2-8, D-61231 Bad Nauheim. Veselin.Mitrovic@kerckhoff.med.uni-giessen.de | lld:pubmed |
| pubmed-article:10552188 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10552188 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10552188 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10552188 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:10552188 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
